These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 29488193)
21. Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension. Šimková K; Joost B; Imanidis G Eur J Pharm Biopharm; 2020 Jan; 146():19-31. PubMed ID: 31734282 [TBL] [Abstract][Full Text] [Related]
22. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Minne A; Boireau H; Horta MJ; Vanbever R Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052 [TBL] [Abstract][Full Text] [Related]
23. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections. Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012 [TBL] [Abstract][Full Text] [Related]
24. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers. Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330 [TBL] [Abstract][Full Text] [Related]
25. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation. Shoyele SA; Sivadas N; Cryan SA AAPS PharmSciTech; 2011 Mar; 12(1):304-11. PubMed ID: 21271316 [TBL] [Abstract][Full Text] [Related]
27. Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients. Yang XB; Wang XB; Pan WS; Xi RG; Wang YN; Liu D; Shi Y; Jiang S Chem Pharm Bull (Tokyo); 2011; 59(8):929-37. PubMed ID: 21804235 [TBL] [Abstract][Full Text] [Related]
28. Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections. Matinkhoo S; Lynch KH; Dennis JJ; Finlay WH; Vehring R J Pharm Sci; 2011 Dec; 100(12):5197-205. PubMed ID: 22020816 [TBL] [Abstract][Full Text] [Related]
29. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition. Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259 [TBL] [Abstract][Full Text] [Related]
30. Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms. Bahamondez-Canas TF; Ferrati S; Moraga-Espinoza DF; Smyth HDC J Pharm Sci; 2018 Aug; 107(8):2172-2178. PubMed ID: 29698726 [TBL] [Abstract][Full Text] [Related]
32. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery. Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500 [TBL] [Abstract][Full Text] [Related]
33. The role of particle properties in pharmaceutical powder inhalation formulations. Chew NY; Chan HK J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421 [TBL] [Abstract][Full Text] [Related]
34. Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach. Sou T; Orlando L; McIntosh MP; Kaminskas LM; Morton DA Int J Pharm; 2011 Dec; 421(2):220-9. PubMed ID: 21963471 [TBL] [Abstract][Full Text] [Related]
35. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate. Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460 [TBL] [Abstract][Full Text] [Related]
36. Manufacturing Stable Bacteriophage Powders by Including Buffer System in Formulations and Using Thin Film Freeze-drying Technology. Zhang Y; Soto M; Ghosh D; Williams RO Pharm Res; 2021 Oct; 38(10):1793-1804. PubMed ID: 34697726 [TBL] [Abstract][Full Text] [Related]
37. Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery. Wilson EM; Luft JC; DeSimone JM Pharm Res; 2018 Aug; 35(10):195. PubMed ID: 30141117 [TBL] [Abstract][Full Text] [Related]
38. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. Bosquillon C; Lombry C; Préat V; Vanbever R J Control Release; 2001 Feb; 70(3):329-39. PubMed ID: 11182203 [TBL] [Abstract][Full Text] [Related]
40. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method. You Y; Zhao M; Liu G; Tang X J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]